
Big Pharma is cost driver of GAVI
MSF demanded the GAVI to immediately stop paying out funds from a remaining US$262m subsidy to Pfizer and GlaxoSmithKline (GSK) for the pneumococcal...

Azeria Therapeutics bags €37.3m in Series B financing round
Series A lead investor CRT Pioneer Fund co-financed the Series B financing round. Azeria said it will use the proceeds to develop its preclinical...

Abcam buys Expedeon’s immunology business
“This purchase price is equivalent to twice Expedeon’s current market capitalisation or excess of 9-times 2018 annual group revenue,” the company...

Sherlock Bioscience and Mologic enter partnership
Mologic said it will invest a part of an expansion to its $4.9m grant from the Bill and Melinda-Gates Foundation to finance access to Sherlock's...

Researchers unravel how ADEP antibiotics work
Fighting antimicrobial resistance has been named one of the prioritary goals by the World Health Organization (WHO). However, as the number of...

Spanish sector attracting more and more investment
According to Spain's biotech association, the investor day attracted 60 investors from nine countries and provided more than 500 partnering...

BASF broadens biotech business by Isobionics acquisition
The acquisition of Isobionics BV (Geleen, The Netherlands) gives the the German world chemistry leader a foothold in the growing US$20.75bn market...